Literature DB >> 17664007

Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells.

Tsuyoshi Shuto1, Takashi Furuta, Judy Cheung, Dieter C Gruenert, Yuko Ohira, Shogo Shimasaki, Mary Ann Suico, Keizo Sato, Hirofumi Kai.   

Abstract

Neutrophils express functional toll-like receptor2 (TLR2) and 4 (TLR4) that are crucial for the production of inflammatory cytokines. Here, we show that dimethylsulfoxide-induced neutrophil-like differentiation of promyelocytic HL-60 cells (dHL-60) results in cells that respond to TLR2 and TLR4 ligands similarly to primary neutrophils. Consistent with the increased responsiveness of the cells to TLR2 ligand, the TLR2 gene was strongly up-regulated in dHL-60 cells. On the other hand, increased surface expression of LPS receptor complex, TLR4/MD2/CD14, was observed without affecting TLR4 gene expression. Thus, the data demonstrate a higher responsiveness of dHL-60 cells to TLR2 and TLR4 ligands because of increased TLR2 and MD2/CD14 gene expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664007     DOI: 10.1016/j.leukres.2007.06.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Posaconazole-Loaded Leukocytes as a Novel Treatment Strategy Targeting Invasive Pulmonary Aspergillosis.

Authors:  Shane R Baistrocchi; Mark J Lee; Melanie Lehoux; Benjamin Ralph; Brendan D Snarr; Robert Robitaille; Donald C Sheppard
Journal:  J Infect Dis       Date:  2017-06-01       Impact factor: 5.226

2.  Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.

Authors:  M R Hutchinson; K M Ramos; L C Loram; J Wieseler; P W Sholar; J J Kearney; M T Lewis; N Y Crysdale; Y Zhang; J A Harrison; S F Maier; K C Rice; L R Watkins
Journal:  Neuroscience       Date:  2009-09-27       Impact factor: 3.590

3.  TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.

Authors:  Gerrit John; Ali O Yildirim; Bruce K Rubin; Dieter C Gruenert; Markus O Henke
Journal:  Am J Respir Cell Mol Biol       Date:  2009-06-05       Impact factor: 6.914

4.  Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils.

Authors:  Keiko Ueno-Shuto; Kosuke Kato; Yukihiro Tasaki; Miki Sato; Keizo Sato; Yuji Uchida; Hiromichi Sakai; Tomomi Ono; Mary Ann Suico; Kazunori Mitsutake; Naofumi Tokutomi; Hirofumi Kai; Tsuyoshi Shuto
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

5.  Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells.

Authors:  Ramani Soundararajan; Punit Prabha; Umesh Rai; Aparna Dixit
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-13       Impact factor: 2.629

6.  Innate immune deficiency of extremely premature neonates can be reversed by interferon-γ.

Authors:  Pierre Tissières; Agnieszka Ochoda; Irène Dunn-Siegrist; Geneviève Drifte; Michel Morales; Riccardo Pfister; Michel Berner; Jérôme Pugin
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

7.  Upregulation of TLR1, TLR2, TLR4, and IRAK-2 Expression During ML-1 Cell Differentiation to Macrophages: Role in the Potentiation of Cellular Responses to LPS and LTA.

Authors:  Kassim Traore; Barry Zirkin; Rajesh K Thimmulappa; Shyam Biswal; Michael A Trush
Journal:  ISRN Oncol       Date:  2012-05-21

8.  DNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription.

Authors:  Takashi Furuta; Tsuyoshi Shuto; Shogo Shimasaki; Yuko Ohira; Mary Ann Suico; Dieter C Gruenert; Hirofumi Kai
Journal:  BMC Mol Biol       Date:  2008-04-21       Impact factor: 2.946

9.  Targeting miR-223 in neutrophils enhances the clearance of Staphylococcus aureus in infected wounds.

Authors:  Maiko de Kerckhove; Katsuya Tanaka; Takahiro Umehara; Momoko Okamoto; Sotaro Kanematsu; Hiroko Hayashi; Hiroki Yano; Soushi Nishiura; Shiho Tooyama; Yutaka Matsubayashi; Toshimitsu Komatsu; Seongjoon Park; Yuka Okada; Rina Takahashi; Yayoi Kawano; Takehisa Hanawa; Keisuke Iwasaki; Tadashige Nozaki; Hidetaka Torigoe; Kazuya Ikematsu; Yutaka Suzuki; Katsumi Tanaka; Paul Martin; Isao Shimokawa; Ryoichi Mori
Journal:  EMBO Mol Med       Date:  2018-10       Impact factor: 12.137

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.